Combination Therapies for the Treatment of Advanced Melanoma: A Review of Current Evidence

por Voskoboynik, Mark, Arkenau, Hendrik-Tobias
Publicado 2014

An update on adjuvant systemic therapies in melanoma

por Samuel, Evangeline, Moore, Maggie, Voskoboynik, Mark, Shackleton, Mark, Haydon, Andrew
Publicado 2019

Correction: Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours

por Lickliter, Jason D., Voskoboynik, Mark, Mileshkin, Linda, Gan, Hui K., Kichenadasse, Ganessan, Zhang, Kathy, Zhang, Maggie, Tang, Zhiyu, Millward, Michael
Publicado 2021

Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours

por Lickliter, Jason D., Voskoboynik, Mark, Mileshkin, Linda, Gan, Hui K., Kichenadasse, Ganessan, Zhang, Kathy, Zhang, Maggie, Tang, Zhiyu, Millward, Michael
Publicado 2021

Immune checkpoint inhibitors and the risk of major atherosclerotic cardiovascular events in patients with high-risk or advanced melanoma: a retrospective cohort study

por Wang, Charlie, Zoungas, Sophia, Yan, Mabel, Wolfe, Rory, Haydon, Andrew, Shackleton, Mark, Voskoboynik, Mark, Moore, Maggie, Andrews, Miles C., Nicholls, Stephen J., Mar, Victoria
Publicado 2022

A capability framework to inform the fundamental requirements for clinical trial unit development, growth and long term success in outer metropolitan and rural areas

por Woollett, Anne, Duncan, Jhodie, Voskoboynik, Mark, Shackleton, Mark, Dooley, Michael, Blum, Robert, McPhee, Narelle, Wright, Tricia, Wong, Zee Wan, Dixon, Jacqueline, Jane, Stephen M.
Publicado 2023

A Phase 1/2 study of the PD-L1 inhibitor, BGB-A333, alone and in combination with the PD-1 inhibitor, tislelizumab, in patients with advanced solid tumours

por Desai, Jayesh, Fong, Peter, Moreno, Victor, Frentzas, Sophia, Meniawy, Tarek, Markman, Ben, Voskoboynik, Mark, Rahman, Tahmina, Budha, Nageshwar, Wu, John, Marlow, Jin, Yang, Silu, Calvo, Emiliano, Martin-Liberal, Juan
Publicado 2023

Prospective analysis of 895 patients on a UK Genomics Review Board

por Moore, David Allan, Kushnir, Marina, Mak, Gabriel, Winter, Helen, Curiel, Teresa, Voskoboynik, Mark, Moschetta, Michele, Rozumna-Martynyuk, Nataliya, Balbi, Kevin, Bennett, Philip, Forster, Martin, Kulkarni, Anjana, Haynes, Debra, Swanton, Charles, Arkenau, Hendrik-Tobias
Publicado 2019

SELECT-3: a phase I study of selumetinib in combination with platinum-doublet chemotherapy for advanced NSCLC in the first-line setting

por Greystoke, Alastair, Steele, Nicola, Arkenau, Hendrik-Tobias, Blackhall, Fiona, Md Haris, Noor, Lindsay, Colin R, Califano, Raffaele, Voskoboynik, Mark, Summers, Yvonne, So, Karen, Ghiorghiu, Dana, Dymond, Angela W, Hossack, Stuart, Plummer, Ruth, Dean, Emma
Publicado 2017

SAFFRON-103: a phase 1b study of the safety and efficacy of sitravatinib combined with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancer

por Zhao, Jun, Yu, Xinmin, Huang, Dingzhi, Ma, Zhiyong, Gao, Bo, Cui, Jiuwei, Chu, Qian, Zhou, Qing, Sun, Meili, Day, Daphne, Wu, Jingxun, Pan, Hongming, Wang, Lifeng, Voskoboynik, Mark, Wang, Zhehai, Liu, Yunpeng, Li, Hui, Zhang, Juan, Peng, Yanyan, Wu, Yi-Long
Publicado 2023

A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in Australia

por Lickliter, Jason D, Gan, Hui K, Voskoboynik, Mark, Arulananda, Surein, Gao, Bo, Nagrial, Adnan, Grimison, Peter, Harrison, Michelle, Zou, Jianjun, Zhang, Lianshan, Luo, Stacey, Lahn, Michael, Kallender, Howard, Mannucci, Andrea, Somma, Catello, Woods, Katherine, Behren, Andreas, Fernandez-Penas, Pablo, Millward, Michael, Meniawy, Tarek
Publicado 2020

BMS-986158, a Small Molecule Inhibitor of the Bromodomain and Extraterminal Domain Proteins, in Patients with Selected Advanced Solid Tumors: Results from a Phase 1/2a Trial

por Hilton, John, Cristea, Mihaela, Postel-Vinay, Sophie, Baldini, Capucine, Voskoboynik, Mark, Edenfield, William, Shapiro, Geoffrey I., Cheng, Michael L., Vuky, Jacqueline, Corr, Bradley, Das, Sharmila, Apfel, Abraham, Xu, Ke, Kozicki, Martin, Ünsal-Kaçmaz, Keziban, Hammell, Amy, Wang, Guan, Ravindran, Palanikumar, Kollia, Georgia, Esposito, Oriana, Coker, Shodeinde, Diamond, Jennifer R.
Publicado 2022

Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)

por Berry, Sneha, Giraldo, Nicolas, Nguyen, Peter, Green, Benjamin, Xu, Haiying, Ogurtsova, Aleksandra, Soni, Abha, Succaria, Farah, Wang, Daphne, Roberts, Charles, Stein, Julie, Engle, Elizabeth, Pardoll, Drew, Anders, Robert, Cottrell, Tricia, Taube, Janis M., Tran, Ben, Voskoboynik, Mark, Kuo, James, Bang, Yung-Lue, Chung, Hyun-Cheo, Ahn, Myung-Ju, Kim, Sang-We, Perera, Ayesh, Freeman, Daniel, Achour, Ikbel, Faggioni, Raffaella, Xiao, Feng, Ferte, Charles, Lemech, Charlotte, Meric-Bernstam, Funda, Werner, Theresa, Hodi, Stephen, Messersmith, Wells, Lewis, Nancy, Talluto, Craig, Dostalek, Mirek, Tao, Aiyang, McWhirter, Sarah, Trujillo, Damian, Luke, Jason, Xu, Chunxiao, BoMarelli, Qi, Jin, Qin, Guozhong, Yu, Huakui, Jenkins, Molly, Lo, Kin-Ming, Halle, Joern-Peter, Lan, Yan, Taylor, Matthew, Vogelzang, Nicholas, Cohn, Allen, Stepan, Daniel, Shumaker, Robert, Dutcus, Corina, Guo, Matthew, Schmidt, Emmett, Rasco, Drew, Brose, Marcia, Vogelzang, Nicholas, Di Simone, Christopher, Jain, Sharad, Richards, Donald, Encarnacion, Carlos, Rasco, Drew, Shumaker, Robert, Dutcus, Corina, Stepan, Daniel, Guo, Matthew, Schmidt, Emmett, Taylor, Matthew, Vogelzang, Nicholas, Encarnacion, Carlos, Cohn, Allen, Di Simone, Christopher, Rasco, Drew, Richards, Donald, Taylor, Matthew, Dutcus, Corina, Stepan, Daniel, Shumaker, Robert, Guo, Matthew, Schmidt, Emmett, Mier, James, An, Jeongshin, Yang, Yeun-yeoul, Lee, Won-Hee, Yang, Jinho, Kim, Jong-kyu, Kim, Hyun Goo, Paek, Se Hyun, Lee, Jun Woo, Woo, Joohyun, Kim, Jong Bin, Kwon, Hyungju, Lim, Woosung, Paik, Nam Sun, Kim, Yoon-Keun, Moon, Byung-In, Janku, Filip, Tan, David, Martin-Liberal, Juan, Takahashi, Shunji, Geva, Ravit, Gucalp, Ayca, Chen, Xueying, Subramanian, Kulandayan, Mataraza, Jennifer, Wheler, Jennifer, Bedard, Philippe
Publicado 2019